SINONASAL CARCINOMA

Clinical trials for SINONASAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new SINONASAL CARCINOMA trials appear

Sign up with your email to follow new studies for SINONASAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Experimental drug tazemetostat offered to patients with rare, aggressive tumors

Disease control NO_LONGER_AVAILABLE

This expanded access program provides tazemetostat, a drug that blocks a protein called EZH2, to adults with serious or life-threatening solid tumors that have lost the INI1 or SMARCA4 protein. Eligible patients must have tried other treatments without success and cannot join a f…

Matched conditions: SINONASAL CARCINOMA

Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC

SINONASAL CARCINOMA

Get alerted when new SINONASAL CARCINOMA trials appear

Experimental drug tazemetostat offered to patients with rare, aggressive tumors